Evidence reviewed: 22 July 2026 · Author: ExtolX Editorial Team · Scientific review: Pending
Educational information for laboratory research audiences. This article does not provide medical advice, dosage or administration guidance.
Bacteriostatic water is sterile water containing a bacteriostatic preservative, commonly benzyl alcohol. Its name does not mean that poor aseptic technique is safe or that every formulation is suitable for every experiment.
Key points
- The compound is a sterile aqueous diluent containing a preservative; the exact formulation and regulatory status must be verified from product documentation.
- Evidence from cells, animals and humans must be interpreted separately.
- Classification depends on the specific product and intended use. ExtolX material remains subject to its research-use documentation.
- Research findings do not establish that independently supplied material is equivalent to a clinical-trial product.
What is it?
Bacteriostatic water is sterile water containing a bacteriostatic preservative, commonly benzyl alcohol. Its name does not mean that poor aseptic technique is safe or that every formulation is suitable for every experiment. In scientific work, identity should be established through appropriate analytical documentation rather than inferred from a product name alone.
How is it thought to work?
Benzyl alcohol can inhibit growth of many bacteria after container entry, but it does not sterilise contaminated material and is not equally effective against all microorganisms.
What does the current evidence show?
- Pharmacopoeial specifications and manufacturer documentation define composition, packaging and quality requirements for regulated products.
- Compatibility depends on the compound, concentration, container, pH and experimental method.
- Preserved water and sterile water without preservative are not interchangeable.
Evidence snapshot
| Evidence level | What it can establish | Main caution |
|---|---|---|
| Laboratory | Biochemical activity and cellular responses under defined conditions | Does not establish effects in an intact organism |
| Animal | Mechanisms and model-specific biological responses | Translation to humans is uncertain |
| Human | Outcomes in the studied population and formulation | Must not be generalised beyond the actual trial |
What remains unknown?
- A universal post-opening lifetime should not be assumed without product-specific validation.
- Preservative activity does not replace sterile handling or contamination controls.
- Information for licensed medicinal products should not be transferred automatically to research-only reagents.
Regulatory and safety context
Classification depends on the specific product and intended use. ExtolX material remains subject to its research-use documentation. A research-use label does not override the way a product is presented, promoted or used. Safety information from one formulation or jurisdiction cannot be transferred automatically to another.
Frequently asked questions
Does published research prove a benefit?
No. A finding must be interpreted in the context of its model, study design, population, formulation and endpoints. Preliminary or preclinical findings are not proof of clinical benefit.
Is research material equivalent to material used in a clinical trial?
Not on the basis of a shared name. Equivalence would require evidence concerning identity, manufacture, purity, formulation, stability and biological activity.
References and further reading
Research-use notice: ExtolX products are supplied strictly for legitimate laboratory research. They are not intended for human or veterinary use, consumption, diagnosis, treatment or prevention of disease.